Cosmo Pharmaceuticals NV
LSE:0RGI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
|
Gazprom Neft' PAO
MOEX:SIBN
|
RU |
|
C
|
CompuGroup Medical SE & Co KgaA
XBER:COP
|
DE |
Wall St Price Targets
0RGI Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for 0RGI is 132.953 CHF with a low forecast of 103.2345 CHF and a high forecast of 170.0166 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RGI's stock price target?
Price Target
132.953
CHF
According to Wall Street analysts, the average 1-year price target for 0RGI is 132.953 CHF with a low forecast of 103.2345 CHF and a high forecast of 170.0166 CHF.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 38%.
What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is 44%.
